- Home
- CVLT vs VRNA Comparison
CVLT vs VRNA Comparison
Compare CVLT & VRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVLT
- VRNA
- Stock Information
- Founded
- CVLT 1996
- VRNA 2005
- Country
- CVLT United States
- VRNA United Kingdom
- Employees
- CVLT N/A
- VRNA N/A
- Industry
- CVLT Computer Software: Prepackaged Software
- VRNA Biotechnology: Pharmaceutical Preparations
- Sector
- CVLT Technology
- VRNA Health Care
- Exchange
- CVLT Nasdaq
- VRNA Nasdaq
- Market Cap
- CVLT 8.2B
- VRNA 8.3B
- IPO Year
- CVLT 2006
- VRNA 2017
- Fundamental
- Price
- CVLT $195.39
- VRNA $106.29
- Analyst Decision
- CVLT Buy
- VRNA Buy
- Analyst Count
- CVLT 10
- VRNA 11
- Target Price
- CVLT $202.22
- VRNA $114.10
- AVG Volume (30 Days)
- CVLT 677.0K
- VRNA 1.3M
- Earning Date
- CVLT 10-28-2025
- VRNA 11-03-2025
- Dividend Yield
- CVLT N/A
- VRNA N/A
- EPS Growth
- CVLT N/A
- VRNA N/A
- EPS
- CVLT 1.79
- VRNA N/A
- Revenue
- CVLT $1,052,925,000.00
- VRNA $221,673,000.00
- Revenue This Year
- CVLT $19.22
- VRNA $896.59
- Revenue Next Year
- CVLT $11.79
- VRNA $77.56
- P/E Ratio
- CVLT $106.49
- VRNA N/A
- Revenue Growth
- CVLT 21.62
- VRNA N/A
- 52 Week Low
- CVLT $128.07
- VRNA $27.54
- 52 Week High
- CVLT $200.69
- VRNA $106.45
- Technical
- Relative Strength Index (RSI)
- CVLT 62.06
- VRNA 68.54
- Support Level
- CVLT $172.50
- VRNA $106.18
- Resistance Level
- CVLT $187.10
- VRNA $106.42
- Average True Range (ATR)
- CVLT 6.47
- VRNA 0.19
- MACD
- CVLT 1.33
- VRNA -0.17
- Stochastic Oscillator
- CVLT 89.84
- VRNA 77.70
About CVLT Commvault Systems Inc.
CommVault Systems Inc provides data and information management software applications and services. The firm sells software licenses and services to large global enterprises, small- and midsize businesses, and government agencies through both its salesforce and its network of reseller partners. Its software solutions include Cleanroom Recovery, HyperScale X, Air Gap Protect, Compliance, Cloud Rewind, and Clumio Backtrack. The company operates in the United States and exports to many other countries.
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.